BibTex RIS Cite

-

Year 2015, Volume: 42 Issue: 2, - , 09.07.2015
https://doi.org/10.5798/diclemedj.0921.2015.02.0569

Abstract

Intravesical instillation of Bacillus Calmette Guerin (BCG) is used in the treatment of patients with superficial bladder carcinoma with efficacy and safety. Although clinically very effective this method is associated with a variety of side effects. In these side effects, Reiter’s Syndrome is occurred most rare. We report here the case of Reiter’s Syndrome following BCG instillation with a different clinical manifestation

References

  • Lamm DL, Stogdill VD, Stogdil BJ, Crispen RG. Complications of Bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 1986;135:272-274.
  • Odom RB, Jome WD, Berger TG. Andrews’ diseases of the
  • skin. 9th ed. United States of America: WB Saunders Company; 2000.
  • Parker CT, Thomas D. Reiter’s syndrome and reactive arthritis. J Am Osteopath Assoc 2000;100:101-104.
  • Graham RB, Champion RH, Burton JL. Reiter’s disease, Ebling FJG Textbook of Dermatology. 5th ed. Turin: Blackwell scientific publications; 1992.
  • Lamm DL, Van Der Mejden ADPM, Morales A, et al. Incidence and treatment of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
  • Kodali VR, Clauge RB. Arthritis after BCG vaccine in a
  • healthy woman. J Intern Med 1998; 244:183-184.
  • Pancaldi P, Van Linthoudt D, Alborino D, et al. Reiter’s Syndrome after intravesical Bacillus Calmette-Guerin treatment for superficial bladder carcinoma. Br J Rheumatol
  • ;32:1096-1098.
  • Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad
  • and more. J Am Acad Dermatol 2008;59:113-121.
  • Ng KL, Chua CB. Reiter’s syndrome post intravesical Bacillus Calmette-Guerin instillations. Asian J Surg 2014, http://
  • dx.doi.org/10.1016/j.asjsur.2014.01.016

İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu

Year 2015, Volume: 42 Issue: 2, - , 09.07.2015
https://doi.org/10.5798/diclemedj.0921.2015.02.0569

Abstract

Intravesical instillation of Bacillus Calmette Guerin (BCG) is used in the treatment of patients with superficial bladder carcinoma with efficacy and safety. Although clinically very effective this method is associated with a variety of side effects. In these side effects, Reiter’s Syndrome is occurred most rare. We report here the case of Reiter’s Syndrome following BCG instillation with a different clinical manifestation.

Key words: Non-invasive bladder carcinoma, intravesical instillation of Bacillus Calmette Guerin (BCG), Reiter’s syndrome

References

  • Lamm DL, Stogdill VD, Stogdil BJ, Crispen RG. Complications of Bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 1986;135:272-274.
  • Odom RB, Jome WD, Berger TG. Andrews’ diseases of the
  • skin. 9th ed. United States of America: WB Saunders Company; 2000.
  • Parker CT, Thomas D. Reiter’s syndrome and reactive arthritis. J Am Osteopath Assoc 2000;100:101-104.
  • Graham RB, Champion RH, Burton JL. Reiter’s disease, Ebling FJG Textbook of Dermatology. 5th ed. Turin: Blackwell scientific publications; 1992.
  • Lamm DL, Van Der Mejden ADPM, Morales A, et al. Incidence and treatment of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
  • Kodali VR, Clauge RB. Arthritis after BCG vaccine in a
  • healthy woman. J Intern Med 1998; 244:183-184.
  • Pancaldi P, Van Linthoudt D, Alborino D, et al. Reiter’s Syndrome after intravesical Bacillus Calmette-Guerin treatment for superficial bladder carcinoma. Br J Rheumatol
  • ;32:1096-1098.
  • Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad
  • and more. J Am Acad Dermatol 2008;59:113-121.
  • Ng KL, Chua CB. Reiter’s syndrome post intravesical Bacillus Calmette-Guerin instillations. Asian J Surg 2014, http://
  • dx.doi.org/10.1016/j.asjsur.2014.01.016
There are 14 citations in total.

Details

Primary Language Turkish
Journal Section Case Reports
Authors

Fatih Elbir This is me

Ramazan Topaktaş This is me

İsmail Başıbüyük This is me

Abdullah Armağan This is me

Publication Date July 9, 2015
Submission Date July 9, 2015
Published in Issue Year 2015 Volume: 42 Issue: 2

Cite

APA Elbir, F., Topaktaş, R., Başıbüyük, İ., Armağan, A. (2015). İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu. Dicle Tıp Dergisi, 42(2). https://doi.org/10.5798/diclemedj.0921.2015.02.0569
AMA Elbir F, Topaktaş R, Başıbüyük İ, Armağan A. İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu. diclemedj. July 2015;42(2). doi:10.5798/diclemedj.0921.2015.02.0569
Chicago Elbir, Fatih, Ramazan Topaktaş, İsmail Başıbüyük, and Abdullah Armağan. “İntravezikal BCG Immunoterapisini Takiben gelişen Reiter Sendromu: Olgu Sunumu”. Dicle Tıp Dergisi 42, no. 2 (July 2015). https://doi.org/10.5798/diclemedj.0921.2015.02.0569.
EndNote Elbir F, Topaktaş R, Başıbüyük İ, Armağan A (July 1, 2015) İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu. Dicle Tıp Dergisi 42 2
IEEE F. Elbir, R. Topaktaş, İ. Başıbüyük, and A. Armağan, “İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu”, diclemedj, vol. 42, no. 2, 2015, doi: 10.5798/diclemedj.0921.2015.02.0569.
ISNAD Elbir, Fatih et al. “İntravezikal BCG Immunoterapisini Takiben gelişen Reiter Sendromu: Olgu Sunumu”. Dicle Tıp Dergisi 42/2 (July 2015). https://doi.org/10.5798/diclemedj.0921.2015.02.0569.
JAMA Elbir F, Topaktaş R, Başıbüyük İ, Armağan A. İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu. diclemedj. 2015;42. doi:10.5798/diclemedj.0921.2015.02.0569.
MLA Elbir, Fatih et al. “İntravezikal BCG Immunoterapisini Takiben gelişen Reiter Sendromu: Olgu Sunumu”. Dicle Tıp Dergisi, vol. 42, no. 2, 2015, doi:10.5798/diclemedj.0921.2015.02.0569.
Vancouver Elbir F, Topaktaş R, Başıbüyük İ, Armağan A. İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu. diclemedj. 2015;42(2).